The selective culture medium is called HAT medium because it contains hypoxanthine, aminopterin, and thymidine. This medium is selective for fused hybridoma cells. Unfused myeloma cells cannot grow because they lack HGPRT, and thus cannot replicate their DNA.
In this post
What does HAT medium do?
HAT medium is used for preparation of monoclonal antibodies. This process is called hybridoma technology. Laboratory animals (e.g., mice) are first exposed to an antigen against which we are interested in isolating an antibody.
Why is HAT medium used in hybrid selection?
Hybridoma selection using HAT medium
Unfused spleen cells are easily selected against since they do not replicate in culture. Unfused myelomas can be selected against using media containing HAT. The aminopterin found in the medium blocks the de novo DNA nucleotide synthesis pathway.
Which type of cell can grow on HAT medium?
hybrid cells
When two types of cells, one with a mutation in TK and the other with a mutation in HGPRT are fused, only the hybrid cells will contain the full complement of necessary enzymes for growth on HAT medium via the salvage pathway. Thus only hybrid cells will grow in HAT medium.
How do you make a medium hat?
HAT Selection Medium
- To prepare 100 mL of 100× HT, dissolve 136 mg of hypoxanthine and 38 mg of thymidine in 100 mL of H2O suitable for tissue culture.
- To prepare 100 mL of 100× A, add 1.76 mg of aminopterin to 100 mL of H2O suitable for tissue culture.
- Filter-sterilize the two solutions independently.
What does HAT medium contain?
HAT medium definition. A selection medium for hybrid cell lines; contains hypoxanthine; aminopterin; thymidine. Only cell lines expressing both hypoxanthine phosphoribosyl transferase (HPRT+) and thymidine kinase (TK+) can survive in this medium.
Who introduced HAT medium?
Littlefield
HAT medium originally developed by Littlefield in 1964 (1) has been one of the key factors that has made hybridoma generation practical. The value of this medium is generally considered from the viewpoint of its ability to inhibit unfused myeloma cell proliferation.
Why aminopterin is added in HAT medium?
Hint: HAT medium is a selective medium used for mammalian cell culture. It uses the method of inhibition mechanism by aminopterin which inhibits dihydrofolate reductase with hypoxanthine and thymidine which are essential intermediates of DNA synthesis. This mechanism is also used in monoclonal antibody production.
Why myeloma cells are used in hybridoma?
Reason: Hybridomas are used to produce monoclonal antibodies. Assertion : Hybridoma cells are shifted to a medium deficient in nutrient which cannot be synthesized by myeloma cells.
Reason : This medium allows selection of hybridoma cells.
How is monoclonal antibody produced?
The traditional monoclonal antibody (mAb) production process usually starts with generation of mAb-producing cells (i.e. hybridomas) by fusing myeloma cells with desired antibody-producing splenocytes (e.g. B cells). These B cells are typically sourced from animals, usually mice.
What is the full form of hat?
The Full form of HAT is Hypoxanthine, or HAT stands for Hypoxanthine, or the full name of given abbreviation is Hypoxanthine.
What is the function of aminopterin?
As a folate analogue, aminopterin competes for the folate binding site of the enzyme dihydrofolate reductase, thereby blocking tetrahydrofolate synthesis, and resulting in depletion of nucleotide precursors and inhibition of DNA, RNA and protein synthesis.
What is the role of HGPRT?
The enzyme hypoxanthine-guanine phosphoribosyltransferase (HGPRT) is one of the central enzymes that recycle the building blocks of RNA and DNA. It attaches a purine base (either guanine or hypoxanthine, a modified form of adenine) to a sugar, creating a nucleotide.
What is the use of aminopterin in hybridoma production?
Aminopterin is a dihydrofolate reductase inhibitor: treatment of cells with aminopterin prevents de novo DNA synthesis, and in the absence of exogenous hypoxanthine and thymidine to supply the salvage pathway, the cells will die.
Why is it called hybridoma?
Hybridoma technology is one of the most common methods used to produce monoclonal antibodies. In this process, antibody-producing B lymphocytes are isolated from mice after immunizing the mice with specific antigen and are fused with immortal myeloma cell lines to form hybrid cells, called hybridoma cell lines.
Why myeloma cells are immortal?
Myeloma cells are preselected to be both nonantibody secreting and sensitive to HAT medium. The resultant fusion product (hybridomas) are thus antibody-secreting and immortal. Unfused myeloma cells die as they cannot survive in the HAT medium, and unfused B cells die as they are not immortal.
Do hybridoma cells have two nuclei?
A hybridoma is a single cell that consists of a cancerous myeloma cell and an immune B-cell which have been fused together into a single body with 1 nucleus and chromosomes from either cell.
What are the steps in antibody production?
In the broad sense, it refers to the entire process of creating a usable specific antibody, including steps of immunogen preparation, immunization, hybridoma creation, collection, screening, isotyping, purification, and labeling for direct use in a particular method.
Why are monoclonal antibodies called monoclonal?
Laboratory-made monoclonal antibodies help stimulate your own immune system. The word “monoclonal” refers to the fact that the antibodies created in the laboratory are clones. They are exact copies of one antibody. The generic names of the products often include the letters “mab” at the end of the name.
How are monoclonal antibodies humanized?
A type of antibody made in the laboratory by combining a human antibody with a small part of a mouse or rat monoclonal antibody. The mouse or rat part of the antibody binds to the target antigen, and the human part makes it less likely to be destroyed by the body’s immune system.
What is HAT short for?
HAT
| Acronym | Definition |
|---|---|
| HAT | Head, Arms, Trunk |
| HAT | Height Above Terrain |
| HAT | Home Automated External Defibrillator Trial (clinical trial) |
| HAT | History of Approximation Theory |